SENISCA awarded Innovate UK grant to develop oligonucleotide therapeutics for the treatment of idiopathic pulmonary fibrosis (IPF).
20. April 2023 02:00 ET
|
Senisca Ltd
Exeter, UK – 20 April 2023: SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and target the diseases of ageing, today announces that it has been...
Exeter Hospital joins North American Partners in Anesthesia
03. Dezember 2018 13:02 ET
|
North American Partners in Anesthesia
MELVILLE, N.Y., Dec. 03, 2018 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA), one of the leading single-specialty anesthesia and perioperative management companies in the US,...
PATH Releases Recommendations To Phillips Exeter Academy Regarding Sexual Misconduct
26. September 2018 09:00 ET
|
PATH
BOSTON, Sept. 26, 2018 (GLOBE NEWSWIRE) -- PATH (Phillips Exeter Alumni for Truth and Healing) today announced it has released a petition with specific recommendations for Phillips Exeter Academy to...
Inaugural Ambius Twitter Chat Set for December 1st at 8 p.m. ET/1 a.m. GMT
08. November 2010 08:00 ET
|
Ambius
BUFFALO GROVE, IL--(Marketwire - November 8, 2010) - Ambius, www.ambius.com, the premier global creator of ambience for businesses, announces their first global Twitter chat on December 1st,...